Fromkin Andrew J. 4
4 · Immunovant, Inc. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Fromkin Drew J
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-10+71,492→ 208,973 totalExercise: $7.94Exp: 2032-01-10→ Common Stock (71,492 underlying) - Award
Common Stock
2022-01-10+21,726→ 67,426 total
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
- [F3]Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.